Ziopharm Oncology Inc – ‘8-K’ for 6/29/20 – ‘EXCEL’

On:  Wednesday, 7/1/20, at 8:00am ET   ·   For:  6/29/20   ·   Accession #:  1193125-20-184639   ·   File #:  1-33038

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     43K 
 2: EX-10.1     Material Contract                                   HTML    158K 
 7: R1          Document and Entity Information                     HTML     50K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- d862521d8k_htm                      XML     14K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- ziop-20200629_lab                     XML     57K 
 5: EX-101.PRE  XBRL Presentations -- ziop-20200629_pre              XML     36K 
 3: EX-101.SCH  XBRL Schema -- ziop-20200629                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001193125-20-184639-xbrl      Zip     42K 

‘EXCEL’   —   IDEA Workbook of Financial Reports

This is an IDEA Workbook.

Download this Microsoft® Excel® .xlsx workbook

6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/24  Alaunos Therapeutics, Inc.        10-K       12/31/23   76:9.9M                                   Donnelley … Solutions/FA
 3/07/23  Alaunos Therapeutics, Inc.        10-K       12/31/22   74:12M                                    Donnelley … Solutions/FA
 3/30/22  Alaunos Therapeutics, Inc.        S-8         3/30/22    4:87K                                    Donnelley … Solutions/FA
 3/30/22  Alaunos Therapeutics, Inc.        10-K       12/31/21   91:13M                                    Donnelley … Solutions/FA
 3/01/21  Alaunos Therapeutics, Inc.        10-K       12/31/20   91:12M                                    Donnelley … Solutions/FA
 8/06/20  Alaunos Therapeutics, Inc.        S-8         8/06/20    3:73K                                    Donnelley … Solutions/FA